Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5331966 | 0.90 | SMN1; SMN2 (0.35) | ALDH1A1MAPTGAAMAPK1SMN1; SMN2 | |
| SCHEMBL1997180 | 0.72 | SMN1; SMN2 (0.49) | ALDH1A1MAPTGAAMAPK1SMN1; SMN2 | |
| SCHEMBL1998299 | 0.70 | NR1H2 (0.44) | ALDH1A1MAPT | |
| SCHEMBL2003485 | 0.70 | SMN1; SMN2 (0.54) | ALDH1A1MAPTGAAMAPK1SMN1; SMN2 | |
| SCHEMBL1999789 | 0.65 | NR1H2 (0.49) | SMN1; SMN2 | |
| SCHEMBL1997881 | 0.63 | TOP2A (0.42) | ALDH1A1MAPTGAAMAPK1SMN1; SMN2 | |
| SCHEMBL2001465 | 0.62 | ABCB1 (0.39) | ALDH1A1MAPT | |
| SCHEMBL2000315 | 0.62 | NR1H2 (0.53) | — | |
| SCHEMBL2001466 | 0.62 | NR1H2 (0.45) | ALDH1A1MAPT | |
| SCHEMBL5308618 | 0.62 | NR1H2 (0.36) | ALDH1A1MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1838687-A1 | NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS | AstraZeneca AB (SE) | 2007-10-03 | — | — | EP | claimed |
| WO-2006073366-A1 | NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS | ASTRAZENECA AB (SE) | 2006-07-13 | — | — | WO | claimed |